Skip Navigation

European Journal of Heart Failure 2005 7(3):371-375; doi:10.1016/j.ejheart.2005.01.007
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jaarsma, T.
Right arrow Articles by Van Veldhuisen, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaarsma, T.
Right arrow Articles by Van Veldhuisen, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Management of heart failure in The Netherlands

Tiny Jaarsmaa,*, Flora M. Haaijer-Ruskampb, Heidrun Sturmb and Dirk J. Van Veldhuisena

a Department of Cardiology, University Medical Centre Groningen Groningen, The Netherlands
b Dept. of Clinical Pharmacology, Groningen University Institute of Drug Exploration The Netherlands

* Corresponding author. Tel.: +31 50 3612355; fax: +31 50 3614391. E-mail address: t.jaarsma{at}thorax.umcg.nl


  Abstract

In The Netherlands, the incidence and prevalence of heart failure are rising as is the case in most other European countries. Overall, there are 200,000 patients with heart failure in The Netherlands and around 25,000 hospitalisations annually with a discharge diagnosis of heart failure. Most of these patients are managed in primary care, often together with a cardiologist.

There is an active guideline program in different professional organisations (e.g. general practitioners, cardiologists) and in 2002 a collaborative multidisciplinary guideline for management of chronic heart failure was developed. However, there is clearly room for improvement in the adherence to these guidelines both with regard to the diagnosis and the treatment of HF patients. For example, ACE-I and β-blockers are still under-prescribed. In particular, the more severely ill patients seem to be under treated. At present, general practitioners and cardiologists differ in their views on heart failure, resulting in differences in diagnosis and management. In addition to the multidisciplinary guidelines, several other initiatives have been developed to improve outcomes in these patients, such as rapid access clinics and outpatient heart failure clinics.

Key Words: Heart failure • The Netherlands • diagnosis • treatment • disease management

Received September 9, 2004; Revised December 28, 2004; Accepted January 12, 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
E. S.T.F. Smeulders, J. C.M. van Haastregt, T. Ambergen, J. J.J. Janssen-Boyne, J. Th.M. van Eijk, and G. I.J.M. Kempen
The impact of a self-management group programme on health behaviour and healthcare utilization among congestive heart failure patients
Eur J Heart Fail, June 1, 2009; 11(6): 609 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann
A review of homocysteine and heart failure
Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.